{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:32:29Z","timestamp":1790814749026,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jaip.2020.03.035","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T11:26:01Z","timestamp":1586949961000},"page":"2681-2688.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Serum Eosinophil-Derived Neurotoxin Better Reflect Asthma Control Status Than Blood Eosinophil Counts"],"prefix":"10.1016","volume":"8","author":[{"given":"Jin","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hyang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hee","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Jung","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyouk-Soo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You Sook","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Bom","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Keun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Bum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.03.035_bib1","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0140-6736(13)61536-6","article-title":"Asthma","volume":"382","author":"Martinez","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.03.035_bib2","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1365-2222.2012.03981.x","article-title":"Exacerbations of severe asthma","volume":"42","author":"McDonald","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.03.035_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1398-9995.2003.00386.x","article-title":"Monitoring the allergic inflammation","volume":"59","author":"Venge","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.03.035_bib4","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/j.1398-9995.2008.01742.x","article-title":"The safety of sublingual immunotherapy with one or multiple pollen allergens in children","volume":"63","author":"Agostinis","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.03.035_bib5","doi-asserted-by":"crossref","first-page":"7582057","DOI":"10.1155\/2018\/7582057","article-title":"Eosinophils target therapy for severe asthma: critical points","volume":"2018","author":"Brussino","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jaip.2020.03.035_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.035_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1183\/09031936.06.00137704","article-title":"Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations","volume":"27","author":"Jayaram","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.035_bib8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2222.2008.02958.x","article-title":"Eosinophils: biological properties and role in health and disease","volume":"38","author":"Hogan","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.03.035_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.anai.2014.06.014","article-title":"Association of serum periostin with aspirin-exacerbated respiratory disease","volume":"113","author":"Kim","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.03.035_bib10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/cea.12345","article-title":"Full blood count parameters for the detection of asthma inflammatory phenotypes","volume":"44","author":"Zhang","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.03.035_bib11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/thx.2008.103069","article-title":"Heterogeneity of asthma according to blood inflammatory patterns","volume":"64","author":"Nadif","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2020.03.035_bib12","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.4049\/jimmunol.177.7.4861","article-title":"Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells","volume":"177","author":"Pegorier","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2020.03.035_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1620\/tjem.233.49","article-title":"Expression levels of eosinophil granule protein mRNAs in induced sputum reflect airway hyperresponsiveness and airflow limitation","volume":"233","author":"Jung","year":"2014","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.jaip.2020.03.035_bib14","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.2500\/aap.2015.36.3884","article-title":"Serum eosinophil-derived neurotoxin: correlation with persistent airflow limitation in adults with house-dust mite allergic asthma","volume":"36","author":"Gon","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2020.03.035_bib15","first-page":"97","article-title":"Correlation of eosinophil derived neurotoxin with airway resistance in asthmatics","volume":"60","author":"Badar","year":"2010","journal-title":"J\u00a0Pak Med Assoc"},{"key":"10.1016\/j.jaip.2020.03.035_bib16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4168\/aair.2019.11.3.394","article-title":"Serum levels of eosinophil-derived neurotoxin: a biomarker for asthma severity in adult asthmatics","volume":"11","author":"Lee","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2020.03.035_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3345\/kjp.2013.56.1.8","article-title":"Eosinophil-derived neurotoxin: a novel biomarker for diagnosis and monitoring of asthma","volume":"56","author":"Kim","year":"2013","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.jaip.2020.03.035_bib18","series-title":"Pocket guide for asthma management and prevention. Report No. 95-3659B","year":"1998"},{"key":"10.1016\/j.jaip.2020.03.035_bib19","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1164\/rccm.2408006","article-title":"Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study","volume":"170","author":"Barnes","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.035_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.035_bib21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.alit.2016.05.008","article-title":"Utility of serum eosinophil-derived neurotoxin (EDN) measurement by ELISA in young children with asthma","volume":"66","author":"Kim","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2020.03.035_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/01621459.1961.10482090","article-title":"Multiple comparisons among means","volume":"56","author":"Dunn","year":"1961","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jaip.2020.03.035_bib23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A\u00a0method of comparing the areas under receiver operating characteristic curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.jaip.2020.03.035_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.jaip.2020.03.035_bib25","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.chest.2017.05.019","article-title":"New anti-eosinophil drugs for asthma and COPD: targeting the trait!","volume":"152","author":"Bel","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2020.03.035_bib26","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.03.035_bib27","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1164\/rccm.200905-0695OC","article-title":"Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma","volume":"181","author":"Dweik","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.035_bib28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1164\/ajrccm.157.1.9703002","article-title":"Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma","volume":"157","author":"Crimi","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.035_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1183\/09031936.99.13101599","article-title":"Prednisone-dependent asthma: inflammatory indices in induced sputum","volume":"13","author":"Pizzichini","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.03.035_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/ajrccm.161.1.9809100","article-title":"Changes in sputum eosinophils predict loss of asthma control","volume":"161","author":"Jatakanon","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.035_bib31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jaci.2014.10.026","article-title":"Biomarker-based asthma phenotypes of corticosteroid response","volume":"135","author":"Cowan","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.03.035_bib32","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.03.035_bib33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/1354750X.2013.773078","article-title":"Eosinophil-derived neurotoxin levels at 3 months post-respiratory syncytial virus bronchiolitis are a predictive biomarker of recurrent wheezing","volume":"18","author":"Kim","year":"2013","journal-title":"Biomarkers"},{"key":"10.1016\/j.jaip.2020.03.035_bib34","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3109\/02770901003792833","article-title":"Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity","volume":"47","author":"Kim","year":"2010","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2020.03.035_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0065-2776(08)60351-X","article-title":"The eosinophilic leukocyte: structure and function","volume":"39","author":"Gleich","year":"1986","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jaip.2020.03.035_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4168\/aair.2019.11.1.16","article-title":"Biomarkers for recurrent wheezing and asthma in preschool children","volume":"11","author":"Lee","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2020.03.035_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1399-3038.1998.tb00361.x","article-title":"Eosinophil and mast cell parameters in children with stable moderate asthma","volume":"9","author":"Hoekstra","year":"1998","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2020.03.035_bib38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00408-006-0054-8","article-title":"Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma","volume":"185","author":"Kim","year":"2007","journal-title":"Lung"},{"key":"10.1016\/j.jaip.2020.03.035_bib39","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1034\/j.1398-9995.2000.00858.x","article-title":"Increased END\/EPX in ongoing asthma","volume":"55","author":"Morioka","year":"2000","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.03.035_bib40","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4168\/aair.2018.10.6.686","article-title":"Montelukast reduces serum levels of eosinophil-derived neurotoxin in preschool asthma","volume":"10","author":"Kim","year":"2018","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2020.03.035_bib41","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.5414\/CP202446","article-title":"Characterization of the relationship between dose and blood eosinophil response following subcutaneous administration of mepolizumab","volume":"53","author":"Pouliquen","year":"2015","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2020.03.035_bib42","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820303354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820303354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:23:25Z","timestamp":1761974605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820303354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2213219820303354"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.03.035","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Eosinophil-Derived Neurotoxin Better Reflect Asthma Control Status Than Blood Eosinophil Counts","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}